Oncology Live CME Series - Molecular Sequencing and Novel Therapeutics in Pancreatic Cancer


Oncology Live CME Series - Molecular Sequencing and Novel Therapeutics in Pancreatic Cancer Banner

Add to Calendar Oncology Live CME Series - Molecular Sequencing and Novel Therapeutics in Pancreatic Cancer 7/17/2024 12:30:00 PM 7/17/2024 1:30:00 PM America/Los_Angeles For More Details: https://ucsd.cloud-cme.com/course/courseoverview?EID=2666 Description: The Oncology Live CME series features engaging, live presentations via a virtual platform.Drs. Simeone and Botta will discuss germline/blood/tumor tissue next generation sequencing in pancreatic cancer. They will discuss how clinicians should incorporate this information into their clinical practice and to find clinical trials. They will cover the use of ctDNA in clinical decision making during the perio... false MM/DD/YYYY


Date & Location
Wednesday, July 17, 2024, 12:30 PM - 1:30 PM

Target Audience
Specialties - Gastroenterology/Hepatology, General Surgery, Internal Medicine, Oncology, Primary Care, Radiation Oncology
Professions - Advanced Practice Nurse, Fellow/Resident, Industry Representative, Medical Assistant, Medical Student, Nurse, Physician, Physician Assistant, Scientist / Researcher

Credits
AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours)

Overview

The Oncology Live CME series features engaging, live presentations via a virtual platform. Drs. Simeone and Botta will discuss germline/blood/tumor tissue next generation sequencing in pancreatic cancer. They will discuss how clinicians should incorporate this information into their clinical practice and to find clinical trials. They will cover the use of ctDNA in clinical decision making during the perioperative and surveillance periods. 

Topics discussed will include:

  • Clinical Trials
  • Molecular/Genomic Sequencing
  • ctDNA
  • Resectable and Non-Resectable Pancreatic Cancer Patients

Objectives
Upon completion of this activity, learners should be able to:

  1. Identify what molecular and genomic tests to order and when to order them.
  2. Interpret Genomic data.
  3. Apply Molecular/Genomic data to identify clinical trials.
  4. Integrate ctDNA and genomics into clinical practice.

Registration


Registration is Free! NEW TIME!

Registration must be completed by 12:00pm PT on July 17, 2024 in order to attend.


Accreditation
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of California San Diego School of Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 1.00 hours of credit and list "CME Category 1" as the provider number).

Surgeons: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.